X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8) 8
index medicus (8) 8
central nervous system neoplasms - drug therapy (6) 6
central nervous system neoplasms - radiotherapy (6) 6
aged (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
chemotherapy (5) 5
methotrexate (5) 5
middle aged (5) 5
primary cns lymphoma (5) 5
adult (4) 4
combined modality therapy (4) 4
dosage and administration (4) 4
drug administration schedule (4) 4
female (4) 4
high-dose methotrexate (4) 4
intraocular lymphoma (4) 4
lymphoma (4) 4
lymphoma - drug therapy (4) 4
lymphoma - radiotherapy (4) 4
lymphomas (4) 4
male (4) 4
methotrexate - therapeutic use (4) 4
non-hodgkins-lymphoma (4) 4
oncology (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
cancer (3) 3
central nervous system (3) 3
central-nervous-system (3) 3
consolidation radiotherapy (3) 3
follow-up studies (3) 3
hematology (3) 3
immunocompetent patients (3) 3
radiotherapy (3) 3
therapy (3) 3
antimetabolites, antineoplastic - therapeutic use (2) 2
central nervous system neoplasms - mortality (2) 2
central nervous system neoplasms - surgery (2) 2
cerebrospinal-fluid (2) 2
combined modality therapy - methods (2) 2
cranial irradiation - methods (2) 2
cytarabine (2) 2
cytarabine - adverse effects (2) 2
cytarabine - therapeutic use (2) 2
diseases (2) 2
dose-response relationship, drug (2) 2
drug resistance, neoplasm (2) 2
drug therapy (2) 2
eye neoplasms - drug therapy (2) 2
eye neoplasms - radiotherapy (2) 2
hematology, oncology and palliative medicine (2) 2
immune system diseases (2) 2
kaplan-meier estimate (2) 2
lymphoma, large b-cell, diffuse - drug therapy (2) 2
methotrexate - administration & dosage (2) 2
methotrexate - adverse effects (2) 2
patient outcomes (2) 2
phase-ii multicenter (2) 2
radiation (2) 2
radiation therapy (2) 2
recurrent primary cns (2) 2
remission (2) 2
remission induction (2) 2
retrospective studies (2) 2
salvage therapy (2) 2
stem cell transplantation (2) 2
stem-cell transplantation (2) 2
treatment outcome (2) 2
whole-brain radiotherapy (2) 2
1-beta-d-arabinofuranosylcytosine (1) 1
1st-line treatment (1) 1
abridged index medicus (1) 1
acquired-resistance (1) 1
acute lymphocytic-leukemia (1) 1
analysis (1) 1
antibodies, monoclonal, murine-derived - administration & dosage (1) 1
antibodies, monoclonal, murine-derived - adverse effects (1) 1
antifolates (1) 1
antimetabolites (1) 1
antimetabolites, antineoplastic - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - pharmacokinetics (1) 1
autologous stem cell transplantation (1) 1
b-cell lymphoma (1) 1
biblioteca nazionale braidense (1) 1
body (1) 1
bone-marrow transplantation (1) 1
brain (1) 1
brain neoplasms - drug therapy (1) 1
brain neoplasms - mortality (1) 1
brain neoplasms - radiotherapy (1) 1
brain tumor (1) 1
carbohydrates (1) 1
care and treatment (1) 1
central nervous system diseases (1) 1
central nervous system lymphoma (1) 1
central nervous system neoplasms - genetics (1) 1
central nervous system neoplasms - metabolism (1) 1
central nervous system neoplasms - therapy (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9700, pp. 1512 - 1520
Summary Background Chemotherapy with high-dose methotrexate is the conventional approach to treat primary CNS lymphomas, but superiority of polychemotherapy... 
Internal Medicine | DEFERRED RADIOTHERAPY | MEDICINE, GENERAL & INTERNAL | B-CELL LYMPHOMA | INTERNATIONAL WORKSHOP | RESPONSE CRITERIA | EUROPEAN ORGANIZATION | CONSOLIDATING RADIOTHERAPY | NON-HODGKINS-LYMPHOMA | INITIAL TREATMENT | CENTRAL-NERVOUS-SYSTEM | CEREBROSPINAL-FLUID | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Lymphoma, Non-Hodgkin - radiotherapy | Cranial Irradiation - methods | Central Nervous System Neoplasms - radiotherapy | Adult | Lymphoma, Non-Hodgkin - drug therapy | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Combined Modality Therapy | Remission Induction | Methotrexate - adverse effects | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Aged | Lymphoma, Non-Hodgkin - mortality | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Cytarabine | Patient outcomes | Central nervous system diseases | Dosage and administration | Lymphomas | Drug therapy, Combination | Methotrexate | Drug therapy | Data analysis | Disease | Monoclonal antibodies | Data collection | Radiation therapy | Patients | Tropical diseases | Index Medicus | Abridged Index Medicus
Journal Article
Hematological Oncology, ISSN 0278-0232, 09/2013, Volume 31, Issue 3, pp. 143 - 150
Despite a high proportion of patients with primary CNS lymphoma (PCNSL) experiences failure after/during first‐line treatment, a few studies focused on salvage... 
ifosfamide | etoposide | primary CNS lymphoma | rituximab | autologous stem cell transplantation | Primary CNS lymphoma | Etoposide | Rituximab | Ifosfamide | Autologous stem cell transplantation | 1ST-LINE TREATMENT | IMMUNOCHEMOTHERAPY | INTRAOCULAR LYMPHOMA | PHASE-II | WHOLE-BRAIN RADIOTHERAPY | THERAPY | RESCUE | ONCOLOGY | RECURRENT PRIMARY CNS | CENTRAL-NERVOUS-SYSTEM | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Cranial Nerve Neoplasms - radiotherapy | Recurrence | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Drug Evaluation | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Central Nervous System Neoplasms - surgery | Cranial Nerve Neoplasms - drug therapy | Drug Resistance, Neoplasm | Male | Transplantation, Autologous | Cranial Nerve Neoplasms - surgery | Eye Neoplasms - surgery | Central Nervous System Neoplasms - radiotherapy | Eye Neoplasms - drug therapy | Female | Retrospective Studies | Etoposide - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - surgery | Drug Administration Schedule | Ifosfamide - adverse effects | Kaplan-Meier Estimate | Hematopoietic Stem Cell Transplantation | Etoposide - administration & dosage | Treatment Outcome | Combined Modality Therapy | Cranial Irradiation | Lymphoma, Large B-Cell, Diffuse - radiotherapy | Remission Induction | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Methotrexate - administration & dosage | Aged | Antibodies, Monoclonal, Murine-Derived - adverse effects | Central Nervous System Neoplasms - drug therapy | Peripheral Blood Stem Cell Transplantation | Eye Neoplasms - radiotherapy | Care and treatment | Relapse | Chemotherapy | Lymphomas | Dosage and administration | Methotrexate | Diseases | Cancer | Index Medicus
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 09/2004, Volume 126, Issue 5, pp. 657 - 664
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 80, Issue 1, pp. 169 - 175
Purpose Avoidance radiotherapy or reduction of irradiation doses in patients with primary central nervous system lymphoma (PCNSL) in complete remission (CR)... 
Radiology | Hematology, Oncology and Palliative Medicine | Brain tumor | Neurotoxicity | Radiotherapy | Local control | Central nervous system lymphoma | PRIMARY CNS LYMPHOMA | ONCOLOGY | STRATEGY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Procarbazine - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Male | Cranial Irradiation - methods | Lymphoma - mortality | Central Nervous System Neoplasms - radiotherapy | Lymphoma - drug therapy | Time Factors | Mental Status Schedule | Vincristine - administration & dosage | Adult | Female | Lymphoma - radiotherapy | Remission Induction - methods | Retrospective Studies | Brain Neoplasms - mortality | Brain Neoplasms - radiotherapy | Radiotherapy Dosage | Drug Administration Schedule | Neoplasm Recurrence, Local | Brain Neoplasms - drug therapy | Cranial Irradiation - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Combined Modality Therapy - methods | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Chemotherapy | Patient outcomes | Radiation | Central nervous system | Lymphomas | Dosage and administration | Methotrexate | Cancer | Computed tomography | Remission | Disease control | Lymphoma | Survival | Tumors | Index Medicus | TOMOGRAPHY | IMMUNE SYSTEM DISEASES | NERVOUS SYSTEM | RADIATION DOSES | MEDICINE | LYMPHOMAS | ANTIMETABOLITES | THERAPY | MINIMIZATION | DRUGS | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | BRAIN | RADIOLOGY | DIAGNOSTIC TECHNIQUES | NEOPLASMS | METHOTREXATE | CENTRAL NERVOUS SYSTEM | COMPUTERIZED TOMOGRAPHY | CHEMOTHERAPY | NUCLEAR MEDICINE | ORGANS | DISEASES | DOSES | OPTIMIZATION | BODY
Journal Article
Cancer Letters, ISSN 0304-3835, 2007, Volume 258, Issue 2, pp. 165 - 170
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.